<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.51959.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Atopic biomarker changes after exposure to 
                    <italic>Porphyromonas gingivalis</italic> lipopolysaccharide: a small experimental study in Wistar rats</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved with reservations, 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Nelwan</surname>
                        <given-names>Sindy Cornelia</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7829-6524</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Nugraha</surname>
                        <given-names>Ricardo Adrian</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-0648-0829</uri>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Endaryanto</surname>
                        <given-names>Anang</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Meizarini</surname>
                        <given-names>Asti</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Tedjosasongko</surname>
                        <given-names>Udijanto</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Pradopo</surname>
                        <given-names>Seno</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Utomo</surname>
                        <given-names>Haryono</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Nowwarote</surname>
                        <given-names>Nunthawan</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-5315-5565</uri>
                    <xref ref-type="aff" rid="a6">6</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Pediatric Dentistry, Universitas Airlangga, Surabaya, Jawa Timur, 60235, Indonesia</aff>
                <aff id="a2">
                    <label>2</label>Department of Cardiology and Vascular Medicine, Universitas Airlangga, Surabaya, Jawa Timur, 60235, Indonesia</aff>
                <aff id="a3">
                    <label>3</label>Division of Pediatric Allergy and Immunology, Department of Child Health, Universitas Airlangga, Surabaya, Jawa Timur, 60235, Indonesia</aff>
                <aff id="a4">
                    <label>4</label>Department of Dental Materials, Science and Technology, Universitas Airlangga, Surabaya, Jawa Timur, 60235, Indonesia</aff>
                <aff id="a5">
                    <label>5</label>Department of Forensic Odontology, Universitas Airlangga, Surabaya, Jawa Timur, 60235, Indonesia</aff>
                <aff id="a6">
                    <label>6</label>Centre de Recherche des Cordeliers, INSERM UMRS 1138, Molecular Oral Pathophysiology, Universit&#x00e9; de Paris, Sorbonne Universit&#x00e9;, Paris, 75006, France</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:sindy-c-n@fkg.unair.ac.id">sindy-c-n@fkg.unair.ac.id</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>11</day>
                <month>5</month>
                <year>2021</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2021</year>
            </pub-date>
            <volume>10</volume>
            <elocation-id>371</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>4</day>
                    <month>5</month>
                    <year>2021</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Nelwan SC et al.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/10-371/pdf"/>
            <abstract>
                <p>
                    <bold>Background</bold>: IgE and IgG
                    <sub>4</sub> are implicated in atopic development and clinically utilized as major biomarkers. Atopic responses following certain pathogens, such as 
                    <italic toggle="yes">Porphyromonas gingivalis </italic>(Pg),
                    <italic toggle="yes"> </italic>are currently an area of interest for further research. The aim of this study is to measure the level of IgE, IgG
                    <sub>4</sub>, and IgG
                    <sub>4</sub>/IgE ratio periodically after exposure of periodontal pathogen Pg lipopolysaccharide (LPS).</p>
                <p> 
                    <bold>Methods</bold>: We used 16 Wistar rats (
                    <italic toggle="yes">Rattus norvegicus</italic>) randomly subdivided into four groups: Group 1,&#x00a0; injected with placebo; Group 2, injected with LPS Pg 0.3 &#x00b5;g/mL; Group 3, injected with LPS Pg 1 &#x00b5;g/mL; and Group 4, injected with LPS Pg 3 &#x00b5;g/mL. Sera from all groups were taken from retro-orbital plexus before and after exposure.</p>
                <p> 
                    <bold>Results</bold>: Levels of IgE and IgG
                    <sub>4</sub> increased significantly following exposure of LPS Pg at day-4 and day-11. Greater increase of IgE rather than IgG
                    <sub>4</sub> contributed to rapid decline of IgG
                    <sub>4</sub>/IgE ratio, detected in the peripheral blood at day-4 and day-11.</p>
                <p> 
                    <bold>Conclusion</bold>: Modulation of atopic responses following exposure to LPS Pg is reflected by a decrease in IgG
                    <sub>4</sub>/IgE ratio that accompanies an increase of IgE.
                    <italic toggle="yes"> </italic>Therefore, Pg, a keystone pathogen during periodontal disease, may have a tendency to disrupt atopic biomarkers.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>allergic diseases</kwd>
                <kwd>atopic inflammatory pathway</kwd>
                <kwd>immunoglobulin</kwd>
                <kwd>periodontal pathogen</kwd>
                <kwd>Porphyromonas gingivalis LPS</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec19">
            <title>Editorial note</title>
            <p>Editorial Note (20
                <sup>th</sup> October 2023): The F1000 Editorial Team has not yet received a new version of this article, as detailed in the Editorial Notes published on 16
                <sup>th</sup> June and 4
                <sup>th</sup> August 2023. The F1000 Editorial Team will no longer be requesting a new version from the authors. Readers should be aware that there is key information missing from the article regarding adverse events, anaesthetic and euthanasia procedures, and ethical approval; this information had been previously given to and verified by the F1000 Editorial Team, but the authors have not yet updated their article. Peer review activity remains suspended until the authors publish a new version of this article.</p>
            <p>Editorial Note (4
                <sup>th</sup> August 2023): The F1000 Editorial Team has not yet received a new version of this article, as detailed in the Editorial Note published on 16
                <sup>th</sup> June 2023. The F1000 Editorial Team is actively contacting the authors to request the new version of the article. Peer review activity remains suspended until the authors publish a new version of this article.</p>
            <p>Editorial Note (16
                <sup>th</sup> June 2023): Since publication, it has been brought to the attention of the Editorial Team that the article was missing key information regarding adverse events, anaesthetic and euthanasia procedures, and ethical approval. The Editorial Team requested further detail and an explanation from the authors in March 2023. The authors provided an adequate response and were requested by the Editorial Team to create a new version of the article to include the additional details. Peer review activity has been suspended until the authors publish a new version of this article.</p>
        </sec>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>The oral cavity is the habitat of numerous bacteria, including 
                <italic toggle="yes">Porphyromonas gingivalis</italic> (Pg). Pg is a gram negative, facultative anaerobic pathogen, which is responsible in causing gingivitis or periodontitis.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> In low-income countries, gingivitis and periodontitis can affect up to 90% of the adult population.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> Rather than alveolar bone and ligament destruction, Pg is believed to be involved with the development of atopic responses in a susceptible host.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> Following Pg infection, hosts&#x2019; adaptive immune response (both cell-mediated and humoral-mediated) could induce a systemic inflammatory reaction, not only just local destruction of tooth-supporting tissues.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> Although periodontal pathogens, such as Pg, play a major role in the initiation of local and systemic inflammatory reaction,
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup> the host aberrant immune responses require further study. Since humoral immune responses are stimulated following Pg infection, there might be a link to the occurrence of atopy.</p>
            <p>Despite long-standing research about hygiene hypothesis for several decades, there is an unequivocally accepted fact that the prevalence of atopy increases more among children who have periodontal pathogen colonization or infection.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> While endorsing these hygiene hypothesis approaches, there is an alternative hypothesis in which exposure to some periodontal pathogens will exclusively trigger an &#x201c;immunoglobulin-E skew&#x201d; rather than reducing it.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup> Within the context of the hygiene hypothesis, the most essential microbial exposures needed to be studied is the biomolecular relationship between host antibody and regulatory T-cell with lipopolysaccharide (LPS), an endotoxin released by Pg to affect host immune reaction.</p>
            <p>Hygiene hypothesis principles might not be able to answer all phenomenon of increasing incidence of atopy among children with poor oral hygiene.
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup> Some studies report a positive association between the colonization/infection of Pg with the development of allergic diseases,
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup> whereas some studies report no association.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>&#x2013;
                    <xref ref-type="bibr" rid="ref21">21</xref>
                </sup> Due to lack of conclusive evidence about the association between Pg and allergic diseases,
                <sup>
                    <xref ref-type="bibr" rid="ref22">22</xref>
                </sup> we try to measure the level of atopic biomarkers following Pg infection.</p>
            <p>To the best of our knowledge, measuring IgG
                <sub>4</sub> and IgE antibody may have a closer association to atopic profiles, since IgG
                <sub>4</sub> and IgE are released after activation of mature B cells following the modulation of IL-4 and IL-5 released by Th-2 cells during type I hypersensitivity.
                <sup>
                    <xref ref-type="bibr" rid="ref23">23</xref>
                </sup> By looking at the alteration of IgG
                <sub>4</sub> and IgE antibodies level after exposure to these selected components of Pg in a rat model, we hope to understand more deeply the biological mechanism of B-cell production antibodies pattern and humoral immune responses before the clinical manifestation of atopy. We chose a rat model since they are inbred so they are almost identical genetically and their genetic, biological and behavior characteristics closely resemble those of humans.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <sec id="sec3">
                <title>Ethics approval</title>
                <p>This article was reported in line with the ARRIVE guidelines. Animal experimental study was conducted under the approval of the Institutional Animal Research Ethics Committee of Universitas Airlangga (UNAIR), Surabaya, Indonesia (animal approval no:50/KKEPK.FKG/IV/2015) under the name of Sindy Cornelia Nelwan as the Principal Investigator. The study was carried out in strict accordance to internationally accepted standards of the Guide for the Care and Use of Laboratory Animals of the National Institute of Health. All efforts were made to ameliorate any suffering of animals through using anaesthetic to euthanize the rats at the end of the experimental procedure.</p>
            </sec>
            <sec id="sec4">
                <title>Animals</title>
                <p>
                    <italic toggle="yes">Sample size</italic>
                </p>
                <p>N = (Z
                    <sub>&#x03b1;/2</sub>)
                    <sup>2</sup> s
                    <sup>2</sup>/d
                    <sup>2</sup>, where s is the standard deviation obtained from previous study or pilot study, and d is the accuracy of estimate or how close to the true mean. Z
                    <sub>&#x03b1;/2</sub> is normal deviate for two- tailed alternative hypothesis at a level of significance. Suppose sample size calculated by software is 3 animals per group and researcher is expecting 10% attrition then his final sample size will be 4 animals per group or 16 animals in total.</p>
                <p>
                    <italic toggle="yes">Rats</italic>
                </p>
                <p>The present study used 16 male Wistar rats (
                    <italic toggle="yes">Rattus novergicus</italic>) between eight and ten weeks of age (average body weight 120-150 grams). The rats were housed in microisolator cages and maintained in a constant room temperature ranging from 22&#x00b0;C to 25&#x00b0;C, with a 12-h light/12-h dark cycle, under artificially controlled ventilation, with a relative humidity ranging from 50% to 60%. The rats were fed a standard balanced rodent diet (NUTRILAB CR-1
                    <sup>&#x00ae;</sup>) and water were provided ad libitum.</p>
                <p>Inclusion criteria was male Wistar rats, age 8-10 weeks, with body weight 120-150 grams. Female Wistar rats, diseased, sick, and lazy male Wistar rats were strictly excluded.</p>
            </sec>
            <sec id="sec5">
                <title>Experimental design and groups</title>
                <p>The present study design was a pre-test post-test-controlled unblinded group design using quantitative method. The 16 male Wistar rats were randomized using randomized block sampling and classified into four groups. Each group consisted of 4 matched Wistar rats (age, weight, IgE and IgG
                    <sub>4</sub> baseline characteristic). Group 1 were given placebo (0.9% normal saline solution). Group 2 were given lipopolysaccharide (LPS) of 
                    <italic toggle="yes">Porphyromonas gingivalis</italic> (Pg) (American Type Culture Collection, Rockville, Md.) at dose 0.3 &#x03bc;g/mL. Group 3 were given LPS Pg at dose 1 &#x03bc;g/mL. Group 4 were given LPS Pg at dose 3 &#x03bc;g/mL.</p>
                <p>The rats received LPS by an intra-sulcular injection. Intra-sulcular injection has an advantage due to the its direct delivery of LPS to oral cavity in which the tip of needle is injected slowly at the crestal bone. Longitudinal quantitative measurement was performed; IgE level, IgG
                    <sub>4</sub> level, and IgG
                    <sub>4</sub>/IgE ratio in both groups on day-0 (before treatment), day-4, and day-11. An average of 0.2 ml peripheral blood sera was obtained by Pasteur pipette from retro-orbital plexus, using a lateral approach on each of these days from each rat. The potential expected adverse events were anaphylactic shock, allergic reaction, bleeding and infection. However, to the best our knowledge, there were no expected nor unexpected adverse events in the experimental procedures. Following the end of the experiments, all efforts were made to ameliorate any suffering of animals through injection of sodium pentobarbital anesthetic to euthanize the rats at the end of the experimental procedure.</p>
            </sec>
            <sec id="sec6">
                <title>Level of IgG
                    <sub>4</sub> and IgE</title>
                <p>Sample of the sera were collected and stored at &#x2212;70&#x00b0;C (&#x2212;94&#x00b0;F) at Institute of Tropical Diseases Universitas Airlangga (UNAIR). All sera were assessed by direct-sandwich enzyme-linked immunosorbent assay (ELISA) with mouse IgE antibody (MAB9935) and IgG
                    <sub>4</sub> antibody (MAB9895) under the manufacturer's (R&amp;D System Europe Ltd, Abingdon, UK) protocol. Briefly, the sera were examined using microtiter plates using 25 ml of 3,3&#x2019;,5,5&#x2019;-tetramethylbenzidine to 1 ml of phosphate-citrate buffer plus perborate in a mildly acidic buffer (adjust pH 5.7). Levels of IgG
                    <sub>4</sub> were detected using monoclonal antibody anti-IgG
                    <sub>4</sub>, transferring it to microtiter plates, adding the supplied conjugate, adding blocking solution, diluting plasma sample (1:100,000), and washing between the steps. Level of IgE was detected using monoclonal antibody anti-IgE, following similar steps until diluting the plasma sample (1:200). A minimum value of 0.01 pg/mL for IgE and 0.01 ng/mL for IgG
                    <sub>4</sub> were assigned for below the limit of detection. We used 3,3&#x2019;,5,5&#x2019;-tetramethylbenzidine as chromogenic substrate, which allows direct visualization of signal development through spectrophotometer.</p>
            </sec>
            <sec id="sec7">
                <title>Statistical analysis</title>
                <p>All measurements were performed at least three times. Results were presented as means &#x00b1; standard errors (SEM). The assumption of the normality for the complete data was assessed by Shapiro-Wilk test. Test of homogeneity of variances was assessed by Levene Statistics. Statistical significance was examined by one-way ANOVA and repeated measure ANOVA using SPSS version 17.0 for Microsoft (IBM corp, Chicago, USA).</p>
            </sec>
        </sec>
        <sec id="sec8" sec-type="results">
            <title>Results</title>
            <sec id="sec9">
                <title>General characteristic investigations</title>
                <p>
                    <xref ref-type="table" rid="T1">Table 1</xref> show the baseline characteristics of the 16 Wistar rats (
                    <italic toggle="yes">Rattus norvegicus).</italic> No significant differences were found for mean age (
                    <italic toggle="yes">p</italic> = 0.774), body weight (
                    <italic toggle="yes">p</italic> = 0.700), baseline IgE (
                    <italic toggle="yes">p</italic> = 0.071), baseline IgG
                    <sub>4</sub> (
                    <italic toggle="yes">p</italic> = 0.770), and baseline IgG
                    <sub>4</sub>/IgE ratio (
                    <italic toggle="yes">p</italic> = 0.053) among the four groups.</p>
                <table-wrap id="T1" orientation="portrait" position="float">
                    <label>Table 1. </label>
                    <caption>
                        <title>General characteristics of study population (n = 16; 4/group).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Variable</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group 1 (control)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group 2 (LPS Pg 0.3 &#x03bc;g/ml)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group 3 (LPS Pg 1 &#x03bc;g/ml)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group 4 (LPS Pg 3 &#x03bc;g/ml)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">
                                    <italic toggle="yes">p value</italic>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">Age (weeks)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8.87 &#x00b1; 0.86</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">9.37 &#x00b1; 0.95</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8.75 &#x00b1; 0.96</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">9.12 &#x00b1; 0.63</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.774</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">Weight (g)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">135.25 &#x00b1; 9.54</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">135.25 &#x00b1; 9.55</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">137.25 &#x00b1; 7.93</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">138.00 &#x00b1; 10.98</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.700</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">Male (%)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">100</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">100</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">100</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">100</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">IgE (pg/mL)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5.69 &#x00b1; 0.28</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5.36 &#x00b1; 0.19</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10.27 &#x00b1; 0.70</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">6.69 &#x00b1; 0.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.071</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">IgG
                                    <sub>4</sub> (ng/mL)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10.74 &#x00b1; 1.41</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">11.76 &#x00b1; 0.85</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">11.91 &#x00b1; 1.66</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10.14 &#x00b1; 1.44</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.770</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">IgG
                                    <sub>4</sub>/IgE (x10
                                    <sup>3</sup>)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.87 &#x00b1; 0.18</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2.20 &#x00b1; 0.13</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.19 &#x00b1; 0.20</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.59 &#x00b1; 0.34</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.053</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn1">
                                <label>*</label>
                                <p>Data are presented as mean&#x2009;&#x00b1;&#x2009;standard error of the mean (SEM).</p>
                            </fn>
                            <fn id="tfn2">
                                <label>**</label>
                                <p>One-way ANOVA for categorical variables; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05.</p>
                            </fn>
                            <fn id="tfn3">
                                <label>***</label>
                                <p>IgE, immune globulin E; IgG
                                    <sub>4</sub>, immune globulin G
                                    <sub>4</sub>; IgG
                                    <sub>4</sub>/IgE, ratio between average IgG
                                    <sub>4</sub> levels divided by average IgE levels.</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Longitudinal observation of serum IgE levels following exposure to LPS Pg.</title>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/55174/138e54cb-c939-4024-a536-7f061da0d61f_figure1.gif"/>
                </fig>
            </sec>
            <sec id="sec10">
                <title>Comparison of serum IgE level between the four groups</title>
                <p>Prior to experiments (day-0), there was no difference of serum IgE level between the four groups (
                    <italic toggle="yes">p</italic> &gt; 0.05). On day-4, there was a significance difference of serum IgE level between all groups (
                    <italic toggle="yes">p</italic> = 0.006). At day-4, the highest average IgE level could be found in Group 3 treated with LPS Pg 1 &#x03bc;g/ml (17.00 &#x00b1; 1.69 pg/ml) and the lowest average IgE level could be found in Group 1 (control) (5.31 &#x00b1; 0.76 pg/ml). On day-11, there was also a significance difference of serum IgE level between both groups (
                    <italic toggle="yes">p</italic> = 0.047). At day-11 the highest average IgE level could be found in Group 2 treated with LPS Pg 0.3 &#x03bc;g/ml (180.34 &#x00b1; 10.42 pg/ml) and the lowest average IgE level could be found in Group 1 (5.06 &#x00b1; 1.86 pg/ml) (
                    <xref ref-type="table" rid="T2">Table 2</xref>).</p>
                <table-wrap id="T2" orientation="portrait" position="float">
                    <label>Table 2. </label>
                    <caption>
                        <title>Comparisons of total serum IgE (pg/mL) between the four groups (mean &#x00b1; SEM).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">n</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE day 0</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE day 4</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE day 11</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 1 (control)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.69 &#x00b1; 0.28</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.31 &#x00b1; 0.76</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.06 &#x00b1; 1.86</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 2 (LPS Pg 0.3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.36 &#x00b1; 0.19</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">9.26 &#x00b1; 0.32</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">180.34 &#x00b1; 10.42</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 3 (LPS Pg 1 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">10.27 &#x00b1; 0.70</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">17.00 &#x00b1; 1.69</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">112.90 &#x00b1; 3.87</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 4 (LPS Pg 3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">6.69 &#x00b1; 0.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">14.79 &#x00b1; 0.86</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">102.01 &#x00b1; 11.04</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">20.733</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">26.171</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">83.758</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.071</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.006</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.047</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn4">
                                <label>*</label>
                                <p>Measured by one-way ANOVA (df1 = 3, df2 = 12, f table 3.490; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05).</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>Longitudinal observation of serum IgG
                            <sub>4</sub> levels following exposure to LPS Pg.</title>
                    </caption>
                    <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/55174/138e54cb-c939-4024-a536-7f061da0d61f_figure2.gif"/>
                </fig>
            </sec>
            <sec id="sec11">
                <title>Comparison of serum IgG
                    <sub>4</sub> level between the four groups</title>
                <p>Prior to experiments (day-0), there was no difference of serum IgG
                    <sub>4</sub> level between the four groups (
                    <italic toggle="yes">p</italic> &gt; 0.05). On day-4, there was a significance difference of serum IgG
                    <sub>4</sub> level between all groups (
                    <italic toggle="yes">p</italic> = 0.008). At day-4, the highest average IgG
                    <sub>4</sub> level could be found in Group 4 (LPS Pg 3 &#x03bc;g/ml; 23.86 &#x00b1; 1.59 ng/ml) and the lowest average IgG
                    <sub>4</sub> level could be found in Group 1 (8.34 &#x00b1; 0.58 ng/ml). On day-11, there was a greater difference of serum IgG
                    <sub>4</sub> level between all groups (
                    <italic toggle="yes">p</italic> = 0.005). At day-10, the highest average IgG
                    <sub>4</sub> level could be found in Group 4 (LPS Pg 3 &#x03bc;g/ml; 63.74 &#x00b1; 4.74 ng/ml) and the lowest average IgG
                    <sub>4</sub> level could be found in Group 1 (13.91 &#x00b1; 0.99 ng/ml) (
                    <xref ref-type="table" rid="T3">Table 3</xref>).</p>
                <table-wrap id="T3" orientation="portrait" position="float">
                    <label>Table 3. </label>
                    <caption>
                        <title>Comparisons of total serum IgG
                            <sub>4</sub> (ng/mL) between the four groups (mean &#x00b1; SEM).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">n</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> day 0</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> day 4</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> day 11</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 1 (control)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">10.74 &#x00b1; 1.41</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">8.34 &#x00b1; 0.58</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">13.91 &#x00b1; 0.99</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 2 (LPS Pg 0.3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.76 &#x00b1; 0.85</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.80 &#x00b1; 0.83</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">39.85 &#x00b1; 2.14</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 3 (LPS Pg 1 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.91 &#x00b1; 1.66</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.98 &#x00b1; 1.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">63.6 &#x00b1; 10.76</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 4 (LPS Pg 3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">10.14 &#x00b1; 1.44</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">23.86 &#x00b1; 1.59</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">63.74 &#x00b1; 4.74</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.379</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">29.265</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">15.665</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.770</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.008</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.005</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn5">
                                <label>*</label>
                                <p>Measured by one-way ANOVA (df1 = 3, df2 = 12, f table 3.490; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05).</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>Comparisons of IgG
                            <sub>4</sub>/IgE ratio between four groups (mean &#x00b1; SEM).</title>
                    </caption>
                    <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/55174/138e54cb-c939-4024-a536-7f061da0d61f_figure3.gif"/>
                </fig>
            </sec>
            <sec id="sec12">
                <title>Ratio of IgG
                    <sub>4</sub>/IgE antibodies between the four groups</title>
                <p>The average IgG
                    <sub>4</sub>/IgE ratio for the control group at day-0, day-4, and day-11 was 1.87 &#x00d7; 10
                    <sup>3</sup>, 1.72 &#x00d7; 10
                    <sup>3</sup>, and 3.62 &#x00d7; 10
                    <sup>3</sup>. In Group 2 (low-dose LPS group; 0.3 &#x03bc;g/ml), the average IgG
                    <sub>4</sub>/IgE ratio was 2.20 &#x00d7; 10
                    <sup>3</sup>, 1.27 &#x00d7; 10
                    <sup>3</sup>, and 0.22 &#x00d7; 10
                    <sup>3</sup>, respectively. In Group 3 (medium-dose LPS group; 1 &#x03bc;g/ml), the average IgG
                    <sub>4</sub>/IgE ratio was 1.19 &#x00d7; 10
                    <sup>3</sup>, 0.69 &#x00d7; 10
                    <sup>3</sup>, and 0.56 &#x00d7; 10
                    <sup>3</sup>, respectively. In Group 4 (high-dose LPS group; 3 &#x03bc;g/ml), the average IgG
                    <sub>4</sub>/IgE ratio was 1.59 &#x00d7; 10
                    <sup>3</sup>, 1.64 &#x00d7; 10
                    <sup>3</sup>, and 0.65 &#x00d7; 10
                    <sup>3</sup>, respectively. All groups exhibited significant differences of IgG
                    <sub>4</sub>/IgE ratios, except at day-0. The highest IgG
                    <sub>4</sub>/IgE ratio at day-4 and day-11 could be found in Group 1. The lowest IgG
                    <sub>4</sub>/IgE ratio at day-4 could be found in Group 3, whilst the lowest ratio at day-11 could be found in Group 2 (
                    <xref ref-type="table" rid="T4">Table 4</xref>).</p>
                <table-wrap id="T4" orientation="portrait" position="float">
                    <label>Table 4. </label>
                    <caption>
                        <title>Comparisons of IgG
                            <sub>4</sub>/IgE ratio (x10
                            <sup>3</sup>) between the four groups (mean &#x00b1; SEM)</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Group</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">n</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE day 0</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE day 4</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE day 11</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 1 (control)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.87 &#x00b1; 0.18</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.72 &#x00b1; 0.36</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">3.62 &#x00b1; 0.85</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 2 (LPS Pg 0.3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">2.20 &#x00b1; 0.13</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.27 &#x00b1; 0.08</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.22 &#x00b1; 0.01</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 3 (LPS Pg 1 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.19 &#x00b1; 0.20</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.69 &#x00b1; 0.03</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.56 &#x00b1; 0.09</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Group 4 (LPS Pg 3 &#x03bc;g/ml)</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.59 &#x00b1; 0.34</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.64 &#x00b1; 0.20</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.65 &#x00b1; 0.08</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">3.418</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.032</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">13.600</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">/</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.053</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.017</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">&lt;0.001</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn6">
                                <label>*</label>
                                <p>Measured by one-way ANOVA (df1 = 3, df2 = 12, f table 3.490; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05).</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
            </sec>
            <sec id="sec13">
                <title>Subgroup analysis</title>
                <p>
                    <italic toggle="yes">Group 2 (0.3 &#x03bc;g/ml LPS Pg)</italic>
                </p>
                <p>Level of IgE were increased dramatically from day-0 to day-11 after experiments (5.36 &#x00b1; 0.19 pg/ml to 180.34 &#x00b1; 10.42 pg/ml; 
                    <italic toggle="yes">p</italic> = 0.011). Level of IgG
                    <sub>4</sub> also increases significantly from day-0 to day-11 after experiments (11.76 &#x00b1; 0.85 ng/ml to 39.85 &#x00b1; 2.14 ng/ml; 
                    <italic toggle="yes">p</italic> = 0.006). On the other hand, IgG
                    <sub>4</sub>/IgE ratio were decreased following experiments (2.20 &#x00b1; 0.13 &#x00d7; 10
                    <sup>3</sup> to 0.22 &#x00b1; 0.01 &#x00d7; 10
                    <sup>3</sup>; 
                    <italic toggle="yes">p</italic> = 0.014) (
                    <xref ref-type="table" rid="T5">Table 5</xref>).</p>
                <table-wrap id="T5" orientation="portrait" position="float">
                    <label>Table 5. </label>
                    <caption>
                        <title>Comparisons of total serum IgE, IgG
                            <sub>4</sub>, and IgG
                            <sub>4</sub>/IgE ratio before and after treatment in Group 2 (exposure of 0.3 &#x03bc;g/mL LPS Pg) (mean &#x00b1; SEM; n = 4).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Time-point</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE (pg/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> (ng/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE (x10
                                    <sup>
                                        <bold>3</bold>
                                    </sup>)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-0 before treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">5.36 &#x00b1; 0.19</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.76 &#x00b1; 0.85</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">2.20 &#x00b1; 0.13</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-4 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">9.26 &#x00b1; 0.32</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.80 &#x00b1; 0.83</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.27 &#x00b1; 0.08</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-11 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">180.34 &#x00b1; 10.42</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">39.85 &#x00b1; 2.14</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.22 &#x00b1; 0.01</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">93.924</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">178.233</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">71.969</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.011</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.006</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.014</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn7">
                                <label>*</label>
                                <p>Measured by repeated measure ANOVA.</p>
                            </fn>
                            <fn id="tfn8">
                                <label>**</label>
                                <p>df times = 2, df error = 14, f table 3.739; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05.</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
                <p>
                    <italic toggle="yes">Group 3 (1 &#x03bc;g/ml LPS Pg)</italic>
                </p>
                <p>Level of IgE were raised dramatically from day-0 to day-11 after experiments (10.27 &#x00b1; 0.70 pg/ml to 112.90 &#x00b1; 3.87 pg/ml; 
                    <italic toggle="yes">p</italic> = 0.003). Level of IgG
                    <sub>4</sub> also increased significantly from day-0 to day-11 after experiments (11.91 &#x00b1; 1.66 ng/ml to 63.6 &#x00b1; 10.76 ng/ml; 
                    <italic toggle="yes">p</italic> = 0.027). On the other hand, IgG
                    <sub>4</sub>/IgE ratio declined following experiments (1.19 &#x00b1; 0.20 &#x00d7; 10
                    <sup>3</sup> to 0.56 &#x00b1; 0.09 &#x00d7; 10
                    <sup>3</sup>; 
                    <italic toggle="yes">p</italic> = 0.362) (
                    <xref ref-type="table" rid="T6">Table 6</xref>).</p>
                <table-wrap id="T6" orientation="portrait" position="float">
                    <label>Table 6. </label>
                    <caption>
                        <title>Comparisons of total serum IgE, IgG
                            <sub>4</sub>, and IgG
                            <sub>4</sub>/IgE ratio before and after treatment in Group 3 (exposure of 1 &#x03bc;g/mL LPS Pg) (mean &#x00b1; SEM; n = 4).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Time-point</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE (pg/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> (ng/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE (x10
                                    <sup>
                                        <bold>3</bold>
                                    </sup>)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-0 before treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">10.27 &#x00b1; 0.70</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.91 &#x00b1; 1.66</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.19 &#x00b1; 0.20</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-4 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">17.00 &#x00b1; 1.69</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">11.98 &#x00b1; 1.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.69 &#x00b1; 0.03</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-11 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">112.90 &#x00b1; 3.87</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">63.6 &#x00b1; 10.76</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.56 &#x00b1; 0.09</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">294.526</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">35.437</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.760</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.003</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.027</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.362</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn9">
                                <label>*</label>
                                <p>Measured by repeated measure ANOVA.</p>
                            </fn>
                            <fn id="tfn10">
                                <label>**</label>
                                <p>df times = 2, df error = 14, f table 3.739; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05.</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
                <p>
                    <italic toggle="yes">Group 4 (3 &#x03bc;g/ml LPS Pg)</italic>
                </p>
                <p>Level of IgE were raised dramatically from day-0 to day-11 after experiments (6.69 &#x00b1; 0.61 pg/ml to 102.01 &#x00b1; 11.04 pg/ml; 
                    <italic toggle="yes">p</italic> = 0.009). Level of IgG
                    <sub>4</sub> were also increase significantly from day-0 to day-11 after experiments (10.14 &#x00b1; 1.44 ng/ml to 63.74 &#x00b1; 4.74 ng/ml; 
                    <italic toggle="yes">p</italic> = 0.029). On the other hand, IgG
                    <sub>4</sub>/IgE ratio declined following experiments (1.59 &#x00b1; 0.34 &#x00d7; 10
                    <sup>3</sup> to 0.65 &#x00b1; 0.08 &#x00d7; 10
                    <sup>3</sup>; 
                    <italic toggle="yes">p</italic> = 0.113) (
                    <xref ref-type="table" rid="T7">Table 7</xref>).</p>
                <table-wrap id="T7" orientation="portrait" position="float">
                    <label>Table 7. </label>
                    <caption>
                        <title>Comparisons of total serum IgE, IgG
                            <sub>4</sub>, and IgG
                            <sub>4</sub>/IgE ratio before and after treatment in Group 4 (exposure of 3 &#x03bc;g/mL LPS Pg) (mean &#x00b1; SEM; n = 4).</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Time-point</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgE (pg/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub> (ng/mL)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IgG
                                    <sub>
                                        <bold>4</bold>
                                    </sub>/IgE (x10
                                    <sup>
                                        <bold>3</bold>
                                    </sup>)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-0 before treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">6.69 &#x00b1; 0.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">10.14 &#x00b1; 1.44</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.59 &#x00b1; 0.34</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-4 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">14.79 &#x00b1; 0.86</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">23.86 &#x00b1; 1.59</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">1.64 &#x00b1; 0.20</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">Day-11 after treatment</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">102.01 &#x00b1; 11.04</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">63.74 &#x00b1; 4.74</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.65 &#x00b1; 0.08</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">F statistic</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">111.386</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">32.929</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">7.841</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">
                                    <italic toggle="yes">p</italic> value</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.009</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.029</td>
                                <td align="left" colspan="1" rowspan="1" valign="bottom">0.113</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn11">
                                <label>*</label>
                                <p>Measured by repeated measure ANOVA.</p>
                            </fn>
                            <fn id="tfn12">
                                <label>**</label>
                                <p>df times = 2, df error = 14, f table 3.739; significant at 
                                    <italic toggle="yes">p</italic> &lt; 0.05.</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
            </sec>
        </sec>
        <sec id="sec14" sec-type="discussion">
            <title>Discussion</title>
            <p>Several mechanisms have been suggested to alter atopic inflammatory responses following LPS Pg infection. One of the mechanisms proven in this study is an elevation of IgE antibody and reduction of IgG
                <sub>4</sub>/IgE ratio.
                <sup>
                    <xref ref-type="bibr" rid="ref24">24</xref>
                </sup> As far as we have known, Th-1 and Th-2 cells are not two different CD4+ T-cell subsets, but it represents polarized forms of the highly heterogenous CD4+ Th cell&#x2013;mediated immune response. Host genetic and microenvironmental factors could have contributed with series of modulatory factors including:
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> the ligation of T-cell receptor (TCR);
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> the activation of costimulatory molecules and its particular components;
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> the predominance of an inflammatory cytokine in the local environment; and
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> the number of postactivation cell divisions following exposure to antigens. Down-regulation of the Th-1 cell is associated with depression of cell-mediated immune response and stimulation of humoral immune response, thus pathogens are able to evade immune clearance.
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup>
            </p>
            <p>
                <italic toggle="yes">Porphyromonas gingivalis</italic> possess very sophisticated defense mechanisms against host immune responses. These pathogens produce capsules containing long chain LPS which is designed effectively to counter membrane attack complex. These long chain LPS can also downgrade cell-mediated immunity by shifting Th-1 into Th-2 which less dangerous to pathogens.
                <sup>
                    <xref ref-type="bibr" rid="ref26">26</xref>
                </sup> LPS may have an essential role in switching cell-mediated to humoral-mediated immune responses.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup> LPS Pg antigen is processed and presented on its surface with MHC-II molecule. Recent studies suggest an activation of alternative complement pathway, disruption of classical complement pathway, modulation of antigen presenting cells, and downregulation of anti-inflammatory cytokines are responsible for the Th2-skewed immune response following exposure to LPS Pg. Predominance shifting from Th-1 into Th-2 occurs in several extra-lymphoid tissues; the ideal site for 
                <italic toggle="yes">Porphyromonas gingivalis</italic> is the oral cavity.
                <sup>
                    <xref ref-type="bibr" rid="ref28">28</xref>
                </sup>
            </p>
            <p>Interleukin-4 (IL-4), which is produced by naive T cells, acts as autocrine manner known to be responsible for the differentiation and activation of Th-2 phenotype.
                <sup>
                    <xref ref-type="bibr" rid="ref29">29</xref>
                </sup> Guo et al (2014) shows upon the occurrence and development of allergic diseases, there is a complex pathobiology which results in an imbalance of Th-1/Th-2.
                <sup>
                    <xref ref-type="bibr" rid="ref30">30</xref>
                </sup> In an atopic disease such as bronchial asthma or urticaria, naive T cell can differentiate into Th-2 under IL-4&#x2013;induced STAT6 and GATA-3 transcription factors.
                <sup>
                    <xref ref-type="bibr" rid="ref30">30</xref>
                </sup> Th-2 predominant immune response will automatically stimulate plasma cell to release IgE and IgG
                <sub>4</sub>.
                <sup>
                    <xref ref-type="bibr" rid="ref31">31</xref>
                </sup> Upon re-exposure of antigen or allergen, binding of the allergen to IgE orchestrates the adaptive immune system to initiate rapid sensitization. Frequent sensitization is a major risk factor for the development of allergic diseases such as urticaria, bronchial asthma, hay fever or atopic dermatitis/eczema.
                <sup>
                    <xref ref-type="bibr" rid="ref32">32</xref>
                </sup>
            </p>
            <p>Our previous study used whole-cell body of 
                <italic toggle="yes">Porphyromonas gingivalis</italic> to study different molecular responses in Wistar rats. Our first project studied the association between periodontal pathogen and host innate immunity. Exposure to 
                <italic toggle="yes">Porphyromonas gingivalis</italic> had been shown to stimulate level of TLR2 and depress level of TLR4.
                <sup>
                    <xref ref-type="bibr" rid="ref33">33</xref>
                </sup> Our findings might indicate that several bacterial properties can turn-off host innate immunity and host inflammatory response. Our second project studied the association between periodontal pathogen and host adaptive immunity. We summarized that high dose CFU of Pg stimulates fold increase of Th-2 cytokines (IL-4, IL-5 and IL-13) and decrease of Th-1 cytokines (IFN-&#x03b3; and IL-17).
                <sup>
                    <xref ref-type="bibr" rid="ref34">34</xref>
                </sup> These were the cornerstone to continue our project in studying LPS as the most important component of these bacteria.</p>
            <p>At this moment, both total IgE or specific IgE antibodies have little diagnostic value in the occurrence of allergic manifestation. Even total or specific IgE is increasing, yet the manifestation of allergy doesn&#x2019;t usually develop, since IgG
                <sub>4</sub> level also increases as a counter-regulator.
                <sup>
                    <xref ref-type="bibr" rid="ref35">35</xref>
                </sup> It means that even human or rat become susceptible to atopic allergy due to the increasing level of IgE, body mechanism is able to provide protection, with increased IgG
                <sub>4</sub> as a counter response to prevent manifestation of allergic diseases and immediate hypersensitivity. Thus, exposure of LPS Pg will develop chance of atopic and hypersensitivity markers, but manifestation of allergic reaction is a complex pattern.
                <sup>
                    <xref ref-type="bibr" rid="ref36">36</xref>
                </sup> IgG
                <sub>4</sub>/IgE ratio has closer accuracy to detect any alteration of atopic inflammatory pathway. Increase level of IgE, which isn&#x2019;t accompanied by IgG
                <sub>4</sub>, can be seen in patients with urticaria or atopic dermatitis.
                <sup>
                    <xref ref-type="bibr" rid="ref37">37</xref>
                </sup> IgE-switched B cells are much more likely to differentiate into plasma cells, whereas IgG
                <sub>4</sub>-switched B cells are less likely to differentiate.
                <sup>
                    <xref ref-type="bibr" rid="ref38">38</xref>
                </sup> This reason would explain why IgE antibody is the most dominant antibody in the development of atopic inflammatory pathway, whereas IgG
                <sub>4</sub> antibodies become prominent later during chronic non-atopic stimulation.
                <sup>
                    <xref ref-type="bibr" rid="ref39">39</xref>
                </sup> According to this reason, IgG
                <sub>4</sub>/IgE ratio may predict atopic responses more accurately than total or specific IgE level.</p>
            <sec id="sec15">
                <title>Limitations and strengths</title>
                <p>Several limitations should be highlighted. First, this study had limitations with regard to very small number of samples which can increase the likelihood of error and imprecision. Second, results from animal models often do not translate into replications in humans.
                    <sup>
                        <xref ref-type="bibr" rid="ref40">40</xref>
                    </sup> IgE antibody responses in Wistar rats are typically transient, whereas the atopic IgE response in human persists for many years.
                    <sup>
                        <xref ref-type="bibr" rid="ref41">41</xref>
                    </sup> Other crucial difference is IgG
                    <sub>4</sub>/IgE ratio, which is usually much higher in the Wistar rats than humans.
                    <sup>
                        <xref ref-type="bibr" rid="ref42">42</xref>&#x2013;
                        <xref ref-type="bibr" rid="ref43">43</xref>
                    </sup> These factors may have an impact on the interpretation of our results. Thus, the findings should be interpreted within the context of this study and its limitations. The strengths of the study were its high statistical power and the homogeneity of each group to enable comparison between groups and periods.</p>
            </sec>
        </sec>
        <sec id="sec16" sec-type="conclusion">
            <title>Conclusion</title>
            <p>Several experiments in rats indicate that exposure to LPS Pg may have a tendency to increase levels of IgE and IgG
                <sub>4</sub>. On the contrary, declining IgG
                <sub>4</sub>/IgE ratio following exposure to LPS Pg suggests the potential role of LPS Pg for isotype switching from IgG
                <sub>4</sub> to IgE. The results of the present study favor indirect isotype switching route for most IgE as secondary responses from LPS Pg infection that leads to systemic atopic inflammatory pathway.</p>
        </sec>
        <sec id="sec17">
            <title>Data availability</title>
            <sec id="sec18">
                <title>Underlying data</title>
                <p>Figshare: Raw Data - Atopic Biomarker Changes after Exposure to Porphyromonas gingivalis Lipopolysaccharide: A Small Experimental Study in Wistar Rat, 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.14350271.v1">https://doi.org/10.6084/m9.figshare.14350271.v1</ext-link>.
                    <sup>
                        <xref ref-type="bibr" rid="ref44">44</xref>
                    </sup>
                </p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>Data fixed LPS grup A.sav (Group 1 results)</p>
                        </list-item>
                        <list-item>
                            <label>-</label>
                            <p>Data fixed LPS grup B1.sav (Group 2 results)</p>
                        </list-item>
                        <list-item>
                            <label>-</label>
                            <p>Data fixed LPS grup B2.sav (Group 3 results)</p>
                        </list-item>
                        <list-item>
                            <label>-</label>
                            <p>Data fixed LPS grup B3.sav (Group 4 results)</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgments</title>
            <p>This project is fully supported by Agung Sosiawan as Dean of Universitas Airlangga College of Dentistry and Coen Pramono as Director of Airlangga Oral and Dental Hospital. We would like to acknowledge Harjanto from Physiology Department and Indrawati Retno from Biochemistry Department for providing material and reagent generation. We also thank all lecturers and research assistants from Universitas Airlangga, who are willing to help in the technical aspect.</p>
            <p>A previous version of this article is available on bioRXiv: 
                <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2021.01.14.426656">https://doi.org/10.1101/2021.01.14.426656</ext-link>.</p>
        </ack>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Herrero</surname>
                            <given-names>ER</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fernandes</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Verspecht</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Dysbiotic Biofilms Deregulate the Periodontal Inflammatory Response.</article-title>
                    <source>

                        <italic toggle="yes">J Dent Res.</italic>
</source>
                    <year>2018</year>;<volume>97</volume>(<issue>5</issue>):<fpage>547</fpage>&#x2013;<lpage>55</lpage>.
                    <pub-id pub-id-type="pmid">29394879</pub-id>
                    <pub-id pub-id-type="doi">10.1177/0022034517752675</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mazurek-Mochol</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Majorczyk</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Banach</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The influence of KIR gene presence/absence polymorphisms on the development of periodontal disease in smokers and non-smokers.</article-title>
                    <source>

                        <italic toggle="yes">Cent Eur J Immunol.</italic>
</source>
                    <year>2017</year>;<volume>42</volume>(<issue>4</issue>):<fpage>347</fpage>&#x2013;<lpage>53</lpage>.
                    <pub-id pub-id-type="pmid">29472811</pub-id>
                    <pub-id pub-id-type="doi">10.5114/ceji.2017.72796</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5820974</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sperr</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kundi</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tursic</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prevalence of Comorbidities in Periodontitis Patients Compared to the General Austrian Population.</article-title>
                    <source>

                        <italic toggle="yes">J Periodontol.</italic>
</source>
                    <year>2018</year>;<volume>89</volume>(<issue>1</issue>):<fpage>19</fpage>&#x2013;<lpage>27</lpage>.
                    <pub-id pub-id-type="pmid">28844189</pub-id>
                    <pub-id pub-id-type="doi">10.1902/jop.2017.170333</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tarannum</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Faizuddin</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Effect of gene polymorphisms on periodontal diseases.</article-title>
                    <source>

                        <italic toggle="yes">Indian. J Hum Genet.</italic>
</source>
                    <year>2012</year>;<volume>18</volume>(<issue>1</issue>):<fpage>9</fpage>&#x2013;<lpage>19</lpage>.
                    <pub-id pub-id-type="pmid">22754216</pub-id>
                    <pub-id pub-id-type="doi">10.4103/0971-6866.96638</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3385187</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pathan</surname>
                            <given-names>MM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bhat</surname>
                            <given-names>KG</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Joshi</surname>
                            <given-names>VM</given-names>
                        </name>
</person-group>:
                    <article-title>Comparative evaluation of the efficacy of a herbal mouthwash and chlorhexidine mouthwash on select periodontal pathogens: An in vitro and ex vivo study.</article-title>
                    <source>

                        <italic toggle="yes">J Indian Soc Periodontol.</italic>
</source>
                    <year>2017</year>;<volume>21</volume>(<issue>4</issue>):<fpage>270</fpage>&#x2013;<lpage>275</lpage>.
                    <pub-id pub-id-type="pmid">29456300</pub-id>
                    <pub-id pub-id-type="doi">10.4103/jisp.jisp_382_16</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5813340</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rafiei</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kiani</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sayehmiri</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Study of 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> in periodontal diseases: A systematic review and meta-analysis.</article-title>
                    <source>

                        <italic toggle="yes">Med J Islam Repub Iran.</italic>
</source>
                    <year>2017</year>;<volume>31</volume>:<fpage>62</fpage>.
                    <pub-id pub-id-type="pmid">29445691</pub-id>
                    <pub-id pub-id-type="doi">10.18869/mjiri.31.62</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5804457</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Dowarah</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Verma</surname>
                            <given-names>AK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Agarwal</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health and antioxidant status in weaned piglets.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2018</year>;<volume>13</volume>(<issue>3</issue>):<fpage>e0192978</fpage>.
                    <pub-id pub-id-type="pmid">29518093</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0192978</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5843174</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fishbein</surname>
                            <given-names>AB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fuleihan</surname>
                            <given-names>RL</given-names>
                        </name>
</person-group>:
                    <article-title>The hygiene hypothesis revisited: does exposure to infectious agents protect us from allergy?</article-title>
                    <source>

                        <italic toggle="yes">Curr Opin Pediatr.</italic>
</source>
                    <year>2012</year>;<volume>24</volume>(<issue>1</issue>):<fpage>98</fpage>&#x2013;<lpage>102</lpage>.
                    <pub-id pub-id-type="pmid">22227779</pub-id>
                    <pub-id pub-id-type="doi">10.1097/MOP.0b013e32834ee57c</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tse</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Horner</surname>
                            <given-names>AA</given-names>
                        </name>
</person-group>:
                    <article-title>Allergen tolerance versus the allergic march: the hygiene hypothesis revisited.</article-title>
                    <source>

                        <italic toggle="yes">Curr Allergy Asthma Rep.</italic>
</source>
                    <year>2008</year>;<volume>8</volume>(<issue>6</issue>):<fpage>475</fpage>&#x2013;<lpage>83</lpage>.
                    <pub-id pub-id-type="pmid">18940137</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s11882-008-0088-5</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2869282</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Duan</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhou</surname>
                            <given-names>X</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Relationship between expression of human gingival beta-defensins and levels of periodontopathogens in subgingival plaque.</article-title>
                    <source>

                        <italic toggle="yes">J Periodontal Res.</italic>
</source>
                    <year>2014</year>;<volume>50</volume>(<issue>1</issue>):<fpage>113</fpage>&#x2013;<lpage>122</lpage>.
                    <pub-id pub-id-type="pmid">24814979</pub-id>
                    <pub-id pub-id-type="doi">10.1111/jre.12187</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Tomitaa</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Komiya-Ito</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Imamura</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prevalence of 
                        <italic toggle="yes">Aggregatibacter actinomycetemcomitans</italic>, 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> and 
                        <italic toggle="yes">Tannerella forsythia</italic> in Japanese patients with generalized chronic and aggressive periodontitis.</article-title>
                    <source>

                        <italic toggle="yes">Microb Pathog.</italic>
</source>
                    <year>2013</year>;<volume>61-62</volume>:<fpage>11</fpage>&#x2013;<lpage>15</lpage>.
                    <pub-id pub-id-type="pmid">23608307</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.micpath.2013.04.006</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ting</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hong</surname>
                            <given-names>X</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhaohui</surname>
                            <given-names>Y</given-names>
                        </name>
</person-group>:
                    <article-title>Relationships of five periodontal pathogens causing subgingival plaque in patients with chronic periodontitis under different periodontal conditions.</article-title>
                    <source>

                        <italic toggle="yes">West China J Stomatol.</italic>
</source>
                    <year>2013</year>;<volume>5</volume>:<fpage>518</fpage>&#x2013;<lpage>21</lpage>.
                    <pub-id pub-id-type="pmid">24298807</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Amano</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kuboniwa</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nakagawa</surname>
                            <given-names>I</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prevalence of specific genotypes of 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> fimA and periodontal health status.</article-title>
                    <source>

                        <italic toggle="yes">J Dent Res.</italic>
</source>
                    <year>2000</year>;<volume>79</volume>(<issue>9</issue>):<fpage>1664</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">11023261</pub-id>
                    <pub-id pub-id-type="doi">10.1177/00220345000790090501</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lu</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Feng</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gao</surname>
                            <given-names>X</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Relationship between volatile fatty acids and 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> and 
                        <italic toggle="yes">Treponema denticola</italic> in gingival crevicular fluids of patients with aggressive periodontitis.</article-title>
                    <source>

                        <italic toggle="yes">Beijing Da Xue Xue Bao.</italic>
</source>
                    <year>2013</year>;<volume>45</volume>(<issue>1</issue>):<fpage>12</fpage>&#x2013;<lpage>16</lpage>.
                    <pub-id pub-id-type="pmid">23411512</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Scapoli</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Girardi</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Palmieri</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Microflora and periodontal disease.</article-title>
                    <source>

                        <italic toggle="yes">Dent Res J (Isfahan).</italic>
</source>
                    <year>2012</year>;<volume>9</volume>(<issue>2</issue>):<fpage>S202</fpage>&#x2013;<lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">23814584</pub-id>
                    <pub-id pub-id-type="doi">10.4103/1735-3327.109755</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3692174</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Carinci</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Scapoli</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Girardi</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Oral microflora and periodontal disease: new technology for diagnosis in dentistry.</article-title>
                    <source>

                        <italic toggle="yes">Ann Stomatol.</italic>
</source>
                    <year>2013</year>;<volume>5</volume>(<issue>2</issue>):<fpage>170</fpage>&#x2013;<lpage>3</lpage>.
                    <pub-id pub-id-type="pmid">23991267</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3755798</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Avila-Campos</surname>
                            <given-names>MJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Velasquez-Melendez</surname>
                            <given-names>G</given-names>
                        </name>
</person-group>:
                    <article-title>Prevalence of putative periodontopathogens from periodontal patients and healthy subjects in S&#x00e3;o Paulo SP Brazil.</article-title>
                    <source>

                        <italic toggle="yes">Rev Inst Med trop S. Paulo.</italic>
</source>
                    <year>2002</year>;<volume>44</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>5</lpage>.
                    <pub-id pub-id-type="pmid">11896405</pub-id>
                    <pub-id pub-id-type="doi">10.1590/s0036-46652002000100001</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wilson</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lopatin</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Osborne</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Prevalence of 
                        <italic toggle="yes">Treponema denticola</italic> and 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> in plaque from periodontally- healthy and periodontally-diseased sites.</article-title>
                    <source>

                        <italic toggle="yes">J Med Microbiol.</italic>
</source>
                    <year>1993</year>;<volume>38</volume>:<fpage>406</fpage>&#x2013;<lpage>10</lpage>.
                    <pub-id pub-id-type="pmid">8389879</pub-id>
                    <pub-id pub-id-type="doi">10.1099/00222615-38-6-406</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Riep</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Edesi-Neuss</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Claessen</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Are putative periodontal pathogens reliable diagnostic markers?</article-title>
                    <source>

                        <italic toggle="yes">J Clin Microbiol.</italic>
</source>
                    <year>2009</year>;<volume>47</volume>(<issue>6</issue>):<fpage>1705</fpage>&#x2013;<lpage>11</lpage>.
                    <pub-id pub-id-type="pmid">19386852</pub-id>
                    <pub-id pub-id-type="doi">10.1128/JCM.01387-08</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2691128</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kato</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Imai</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ochiai</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Higher Prevalence of Epstein&#x2013;Barr Virus DNA in Deeper Periodontal Pockets of Chronic Periodontitis in Japanese Patients.</article-title>
                    <source>

                        <italic toggle="yes">PLoS ONE.</italic>
</source>
                    <year>2013</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e71990</fpage>.
                    <pub-id pub-id-type="pmid">23991022</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0071990</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3753341</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kato</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Imai</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ochiai</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Salivary detection of periodontopathic bacteria in Fanconi&#x2019;s anemia patients.</article-title>
                    <source>

                        <italic toggle="yes">Anaerobe.</italic>
</source>
                    <year>2013</year>;<volume>24</volume>:<fpage>32</fpage>&#x2013;<lpage>35</lpage>.
                    <pub-id pub-id-type="pmid">24055631</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.09.005</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rafiei</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kiani</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sayehmiri</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Study of 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> in periodontal diseases: A systematic review and meta-analysis.</article-title>
                    <source>

                        <italic toggle="yes">Med J Islam Repub Iran.</italic>
</source>
                    <year>2017</year>;<volume>31</volume>:<fpage>62</fpage>.
                    <pub-id pub-id-type="pmid">29445691</pub-id>
                    <pub-id pub-id-type="doi">10.18869/mjiri.31.62</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5804457</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Okamoto</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Taniuchi</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sudo</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Predictive value of IgE/IgG
                        <sub>4</sub> antibody ratio in children with egg allergy.</article-title>
                    <source>

                        <italic toggle="yes">Allergy Asthma Clin Immunol.</italic>
</source>
                    <year>2012</year>;<volume>8</volume>:<fpage>9</fpage>.
                    <pub-id pub-id-type="pmid">22676477</pub-id>
                    <pub-id pub-id-type="doi">10.1186/1710-1492-8-9</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3511811</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref24">
                <label>24</label>
                <mixed-citation publication-type="web">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Portnoy</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>IgE in Clinical Allergy and Allergy Diagnosis.</article-title>[accessed on 1 July 2018].
                    <ext-link ext-link-type="uri" xlink:href="http://www.worldallergy.org/professional/allergic_diseases_center/ige/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Herman</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ladics</surname>
                            <given-names>GS</given-names>
                        </name>
</person-group>:
                    <article-title>Allergenic sensitization versus elicitation risk criteria for novel food proteins - short communication.</article-title>
                    <source>

                        <italic toggle="yes">Regul Toxicol Pharmacol.</italic>
</source>
                    <year>2018</year>;<volume>94</volume>:<fpage>283</fpage>&#x2013;<lpage>5</lpage>.
                    <pub-id pub-id-type="pmid">29481837</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.yrtph.2018.02.016</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Matthews</surname>
                            <given-names>CR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Joshi</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>de Jager</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Host-bacterial interactions during induction and resolution of experimental gingivitis in current smokers.</article-title>
                    <source>

                        <italic toggle="yes">J Periodontol.</italic>
</source>
                    <year>2013</year>;<volume>84</volume>(<issue>1</issue>):<fpage>32</fpage>&#x2013;<lpage>40</lpage>.
                    <pub-id pub-id-type="pmid">22420875</pub-id>
                    <pub-id pub-id-type="doi">10.1902/jop.2012.110662</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Finlay</surname>
                            <given-names>BB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McFadden</surname>
                            <given-names>G</given-names>
                        </name>
</person-group>:
                    <article-title>Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens.</article-title>
                    <source>

                        <italic toggle="yes">Cell.</italic>
</source>
                    <year>2006</year>;<volume>124</volume>(<issue>4</issue>):<fpage>767</fpage>&#x2013;<lpage>782</lpage>.
                    <pub-id pub-id-type="pmid">16497587</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.cell.2006.01.034</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Schmid-Hemple</surname>
                            <given-names>P</given-names>
                        </name>
</person-group>:
                    <article-title>Immune defence, parasite evasion strategies and their relevance for &#x2018;macroscopic phenomena&#x2019; such as virulence.</article-title>
                    <source>

                        <italic toggle="yes">Philos Trans R Soc Lond B Biol Sci.</italic>
</source>
                    <year>2009</year>;<volume>364</volume>(<issue>1513</issue>):<fpage>85</fpage>&#x2013;<lpage>98</lpage>.
                    <pub-id pub-id-type="pmid">18930879</pub-id>
                    <pub-id pub-id-type="doi">10.1098/rstb.2008.0157</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2666695</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref29">
                <label>29</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Theodorou</surname>
                            <given-names>GL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Marousi</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ellul</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke.</article-title>
                    <source>

                        <italic toggle="yes">Clin Exp Immunol.</italic>
</source>
                    <year>2008</year>;<volume>152</volume>(<issue>3</issue>):<fpage>456</fpage>&#x2013;<lpage>63</lpage>.
                    <pub-id pub-id-type="pmid">18422734</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1365-2249.2008.03650.x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2453204</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref30">
                <label>30</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Guo</surname>
                            <given-names>HW</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yun</surname>
                            <given-names>CX</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hou</surname>
                            <given-names>GH</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Mangiferin attenuates TH1/TH2 cytokine imbalance in an ovalbumin-induced asthmatic mouse model.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2014</year>;<volume>9</volume>:<fpage>e100394</fpage>.
                    <pub-id pub-id-type="pmid">24955743</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0100394</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4067356</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref31">
                <label>31</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ettinger</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Karnell</surname>
                            <given-names>JL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Henault</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses.</article-title>
                    <source>

                        <italic toggle="yes">Autoimmunity.</italic>
</source>
                    <year>2017</year>;<volume>50</volume>(<issue>1</issue>):<fpage>25</fpage>&#x2013;<lpage>36</lpage>.
                    <pub-id pub-id-type="pmid">28166684</pub-id>
                    <pub-id pub-id-type="doi">10.1080/08916934.2017.1280670</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref32">
                <label>32</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Varricchi</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Raap</surname>
                            <given-names>U</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rivellese</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Human mast cells and basophils-How are they similar how are they different?</article-title>
                    <source>

                        <italic toggle="yes">Immunol Rev.</italic>
</source>
                    <year>2018</year>;<volume>282</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>34</lpage>.
                    <pub-id pub-id-type="pmid">29431214</pub-id>
                    <pub-id pub-id-type="doi">10.1111/imr.12627</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref33">
                <label>33</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nelwan</surname>
                            <given-names>SC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nugraha</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Endaryanto</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Modulating toll-like receptor-mediated inflammatory responses following exposure of whole cell and lipopolysaccharide component from 
                        <italic toggle="yes">Porphyromonas gingivalis</italic> in wistar rat models.</article-title>
                    <source>

                        <italic toggle="yes">Eur J Dent.</italic>
</source>
                    <year>2017</year>;<volume>11</volume>(<issue>4</issue>):<fpage>422</fpage>&#x2013;<lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">29279665</pub-id>
                    <pub-id pub-id-type="doi">10.4103/ejd.ejd_147_17</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5727724</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref34">
                <label>34</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nelwan</surname>
                            <given-names>SC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nugraha</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Endaryanto</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Converging findings from linkage between periodontal pathogen with atopic and allergic immune response.</article-title>
                    <source>

                        <italic toggle="yes">Cytokine.</italic>
</source>
                    <year>2019</year>;<volume>113</volume>:<fpage>89</fpage>&#x2013;<lpage>98</lpage>.
                    <pub-id pub-id-type="pmid">29937409</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.cyto.2018.06.015</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref35">
                <label>35</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Saulite</surname>
                            <given-names>I</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hoetzenecker</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Guenova</surname>
                            <given-names>E</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.</article-title>
                    <source>

                        <italic toggle="yes">Int Arch Allergy Immunol.</italic>
</source>
                    <year>2017</year>;<volume>174</volume>(<issue>3-4</issue>):<fpage>190</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">29130986</pub-id>
                    <pub-id pub-id-type="doi">10.1159/000481255</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref36">
                <label>36</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Garman</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Muns</surname>
                            <given-names>EE</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Unique Inflammatory Mediators and Specific IgE Levels Distinguish Local from Systemic Reactions after Anthrax Vaccine Adsorbed Vaccination.</article-title>
                    <source>

                        <italic toggle="yes">Clin Vaccine Immunol.</italic>
</source>
                    <year>2016</year>;<volume>23</volume>(<issue>8</issue>):<fpage>664</fpage>&#x2013;<lpage>71</lpage>.
                    <pub-id pub-id-type="pmid">27280620</pub-id>
                    <pub-id pub-id-type="doi">10.1128/CVI.00092-16</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4979178</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref37">
                <label>37</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Deo</surname>
                            <given-names>SS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mistry</surname>
                            <given-names>KJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kakade</surname>
                            <given-names>AM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Role played by Th2 type cytokines in IgE mediated allergy and asthma.</article-title>
                    <source>

                        <italic toggle="yes">Lung India.</italic>
</source>
                    <year>2010</year>;<volume>27</volume>(<issue>2</issue>):<fpage>66</fpage>&#x2013;<lpage>71</lpage>.
                    <pub-id pub-id-type="pmid">20616938</pub-id>
                    <pub-id pub-id-type="doi">10.4103/0970-2113.63609</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2893428</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref38">
                <label>38</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kubo</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>T follicular helper and TH2 cells in allergic responses.</article-title>
                    <source>

                        <italic toggle="yes">Allergol Int.</italic>
</source>
                    <year>2017</year>;<volume>66</volume>(<issue>3</issue>):<fpage>377</fpage>&#x2013;<lpage>81</lpage>.
                    <pub-id pub-id-type="pmid">28499720</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.alit.2017.04.006</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref39">
                <label>39</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fear</surname>
                            <given-names>DJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Willis-Owen</surname>
                            <given-names>SA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Global gene regulation during activation of immunoglobulin class switching in human B cells.</article-title>
                    <source>

                        <italic toggle="yes">Sci Rep.</italic>
</source>
                    <year>2016</year>;<volume>6</volume>:<fpage>37988</fpage>.
                    <pub-id pub-id-type="pmid">27897229</pub-id>
                    <pub-id pub-id-type="doi">10.1038/srep37988</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5126563</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref40">
                <label>40</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Platts-Mills</surname>
                            <given-names>TA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vaughan</surname>
                            <given-names>JW</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Blumenthal</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Serum IgG and IgG
                        <sub>4</sub> antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response.</article-title>
                    <source>

                        <italic toggle="yes">Int Arch Allergy Immunol.</italic>
</source>
                    <year>2001</year>;<volume>124</volume>:<fpage>126</fpage>&#x2013;<lpage>9</lpage>.
                    <pub-id pub-id-type="pmid">11306947</pub-id>
                    <pub-id pub-id-type="doi">10.1159/000053689</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref41">
                <label>41</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ramadani</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bowen</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Upton</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ontogeny of human IgE-expressing B cells and plasma cells.</article-title>
                    <source>

                        <italic toggle="yes">Allergy.</italic>
</source>
                    <year>2017</year>;<volume>72</volume>(<issue>1</issue>):<fpage>66</fpage>&#x2013;<lpage>76</lpage>.
                    <pub-id pub-id-type="pmid">27061189</pub-id>
                    <pub-id pub-id-type="doi">10.1111/all.12911</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5107308</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref42">
                <label>42</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Aalberse</surname>
                            <given-names>RC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Platts-Mills</surname>
                            <given-names>TA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rispens</surname>
                            <given-names>T</given-names>
                        </name>
</person-group>:
                    <article-title>The Developmental History of IgE and IgG
                        <sub>4</sub> Antibodies in Relation to Atopy, Eosinophilic Esophagitis, and the Modified TH2 Response.</article-title>
                    <source>

                        <italic toggle="yes">Curr Allergy Asthma Rep.</italic>
</source>
                    <year>2016</year>;<volume>16</volume>(<issue>6</issue>):<fpage>45</fpage>.
                    <pub-id pub-id-type="pmid">27221343</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s11882-016-0621-x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5026408</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref43">
                <label>43</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hatipo&#x011f;lu</surname>
                            <given-names>U</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Subramanian</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Campbell</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Intrasubject Variability in Total IgE Levels in Patients with Moderate to Severe Persistent Allergic Asthma Over 1 Year.</article-title>
                    <source>

                        <italic toggle="yes">J Allergy Clin Immunol Pract.</italic>
</source>
                    <year>2016</year>;<volume>4</volume>(<issue>4</issue>):<fpage>691</fpage>&#x2013;<lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">27039239</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jaip.2016.02.007</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref44">
                <label>44</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nelwan</surname>
                            <given-names>SC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nugraha</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Endaryanto</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Raw Data - Atopic Biomarker Changes after Exposure to Porphyromonas gingivalis Lipopolysaccharide: A Small Experimental Study in Wistar Rat.</article-title>
                    <source>

                        <italic toggle="yes">figshare. Dataset.</italic>
</source>
                    <year>2021</year>.
                    <pub-id pub-id-type="doi">10.6084/m9.figshare.14350271.v1</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
        <glossary>
            <title>Abbreviations</title>
            <def-list list-content="abbreviation" list-type="simple">
                <def-item>
                    <term id="G1">ANOVA</term>
                    <def>
                        <p>analysis of variant</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G2">BCR</term>
                    <def>
                        <p>B cell receptor</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G3">CD-40</term>
                    <def>
                        <p>Cluster Differentiation-40</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G4">CFU</term>
                    <def>
                        <p>colony-forming unit</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G5">CSR</term>
                    <def>
                        <p>class-switch recombination</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G6">df</term>
                    <def>
                        <p>degree of freedom</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G7">ELISA</term>
                    <def>
                        <p>enzyme-linked immunosorbent assay</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G8">FDA</term>
                    <def>
                        <p>Food and Drug Administration</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G9">HDM</term>
                    <def>
                        <p>house dust mite</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G10">IACUC</term>
                    <def>
                        <p>Institutional Animal Care and Use Committee</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G11">IFN-&#x03b3;</term>
                    <def>
                        <p>gamma-Interferon</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G12">IgE</term>
                    <def>
                        <p>immunoglobulin-E</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G13">IgG
                        <sub>4</sub>
                    </term>
                    <def>
                        <p>immunoglobulin-G

                            <sub>4</sub>
                        </p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G14">IL</term>
                    <def>
                        <p>interleukin</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G15">LLPC</term>
                    <def>
                        <p>long-lived plasma cell</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G16">LPS</term>
                    <def>
                        <p>lipopolysaccharide</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G17">mAb</term>
                    <def>
                        <p>monoclonal antibody</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G18">MAC</term>
                    <def>
                        <p>membrane attack complex</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G19">MHC</term>
                    <def>
                        <p>major histocompatibility complex</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G20">NIH</term>
                    <def>
                        <p>National Institutes of Health</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G21">NGS</term>
                    <def>
                        <p>next-generation sequencing</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G22">NK</term>
                    <def>
                        <p>natural killer cells</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G23">OIT</term>
                    <def>
                        <p>oral immunotherapy</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G24">PAMP</term>
                    <def>
                        <p>pathogen-associated molecular patterns</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G25">PCR</term>
                    <def>
                        <p>Polymerase Chain Reaction</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G26">Pg</term>
                    <def>
                        <p>

                            <italic toggle="yes">Porphyromonas gingivalis</italic>
                        </p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G27">SD</term>
                    <def>
                        <p>standard deviation</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G28">SEM</term>
                    <def>
                        <p>standard error of the mean</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G29">SPSS</term>
                    <def>
                        <p>Statistical Package for the Social Sciences</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G30">Th-1</term>
                    <def>
                        <p>type-1 helper T-cells</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G31">Th-2</term>
                    <def>
                        <p>type-2 helper T-cells</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G32">TNF-&#x03b1;</term>
                    <def>
                        <p>Tumor Necrosis Factor-&#x03b1;</p>
                    </def>
                </def-item>
            </def-list>
        </glossary>
    </back>
    <sub-article article-type="reviewer-report" id="report92330">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.55174.r92330</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Maekawa</surname>
                        <given-names>Tomoki</given-names>
                    </name>
                    <xref ref-type="aff" rid="r92330a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-4597-1316</uri>
                </contrib>
                <aff id="r92330a1">
                    <label>1</label>Center for Advanced Oral Science, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>14</day>
                <month>9</month>
                <year>2021</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Maekawa T</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport92330" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.51959.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>This paper reaches its conclusions based on data from a small number of analysis samples, making it difficult to evaluate. In particular, there are few prerequisite statements and reference papers on the relevance of IgG and IgG4 in periodontitis, and the purpose of the study is not clear. No rationale was given for using Pg LPS in measuring pan-IgG4 and IgE levels that makes this manuscript a simple descriptive survey. 
                <list list-type="bullet">
                    <list-item>
                        <p>Ensure all the references are appropriately selected. Some of the references in this manuscript are not presented correctly. The authors should refer to the comprehensive scientific paper in such a scientific journal.</p>
                    </list-item>
                    <list-item>
                        <p>There are many papers that stated IgG rises when Pg (not only Pg but also the other LPS) is administered, so the authors need to be clear about what is new and what the purpose is.</p>
                    </list-item>
                    <list-item>
                        <p>A more detailed explanation of the relationship between IgG4 and IgG and periodontal disease is needed.</p>
                    </list-item>
                    <list-item>
                        <p>In the Introduction, Ref 2 Mazurek 
                            <italic>et al.</italic> paper is too specific to cite since this paper mentioned the influence of KIR gene presence/absence polymorphisms, which the description has not related to a comprehensive explanation of periodontitis. Ref 3 is also an irrelevant paper, it is a review of comorbidities. Moreover, Refs 4, 5, 7, 8 suddenly appeared immunoglobulin-E skew and is not suitable for citing. Some of the references cannot be found in NCBI (i.e. Refs 14, 24).</p>
                    </list-item>
                    <list-item>
                        <p>Please check all references throughout the paper.</p>
                    </list-item>
                    <list-item>
                        <p>Material and Methods are poorly written. How do the authors isolate LPS from Pg? The authors should describe the strain of Pg you selected.</p>
                    </list-item>
                    <list-item>
                        <p>Discussion, page 8, third line from the back: wrong reference papers are cited.</p>
                    </list-item>
                    <list-item>
                        <p>LPS Pg should be Pg LPS.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>No</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Yes</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Partly</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>No</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>No</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>No</p>
            <p>Reviewer Expertise:</p>
            <p>Immunology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment11351-92330">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Nugraha</surname>
                            <given-names>Ricardo Adrian</given-names>
                        </name>
                        <aff>Cardiology and Vascular Medici, Airlangga University, Surabaya, East Java, Indonesia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>None declared</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>1</day>
                    <month>4</month>
                    <year>2024</year>
                </pub-date>
            </front-stub>
            <body>
                <p>This paper reaches its conclusions based on data from a small number of analysis samples, making it difficult to evaluate. In particular, there are few prerequisite statements and reference papers on the relevance of IgG and IgG4 in periodontitis, and the purpose of the study is not clear. No rationale was given for using Pg LPS in measuring pan-IgG4 and IgE levels that makes this manuscript a simple descriptive survey.</p>
                <p> Answer: thank you for your comment. We have included statement &#x201c;this study had limitations with regard to very small number of samples which can increase the likelihood of error and imprecision&#x201d; in the Limitation subsection, thus readers should be careful when interpreted results of our study</p>
                <p> </p>
                <p> Ensure all the references are appropriately selected. Some of the references in this manuscript are not presented correctly. The authors should refer to the comprehensive scientific paper in such a scientific journal.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> thank you for your suggestion, we have re-checked and replaced several references which are inappropriate.&#x00a0;</p>
                <p> </p>
                <p> There are many papers that stated IgG rises when Pg (not only Pg but also the other LPS) is administered, so the authors need to be clear about what is new and what the purpose is.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> thank you for your very constructive feedback. We understood that several conflicting literatures are existed and try to included them fairly.</p>
                <p> </p>
                <p> A more detailed explanation of the relationship between IgG4 and IgG and periodontal disease is needed.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> thank you for your very constructive feedback. We have added more detailed explanation regarding the relationship between IgG4 and IgG and periodontal disease</p>
                <p> In the Introduction, Ref 2 Mazurek&#x00a0;
                    <italic>et al.</italic>&#x00a0;paper is too specific to cite since this paper mentioned the influence of KIR gene presence/absence polymorphisms, which the description has not related to a comprehensive explanation of periodontitis. Ref 3 is also an irrelevant paper, it is a review of comorbidities. Moreover, Refs 4, 5, 7, 8 suddenly appeared immunoglobulin-E skew and is not suitable for citing. Some of the references cannot be found in NCBI (i.e. Refs 14, 24).</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> thank you for your suggestion, after discussion among co-authors, we have replaced several references which are too specific to support our hypothesis.&#x00a0;</p>
                <p> Please check all references throughout the paper.</p>
                <p> </p>
                <p> 
                    <bold>Answer: </bold>thank you for your suggestion, we have re-checked and replaced several references which are inappropriate.&#x00a0;</p>
                <p> </p>
                <p> Material and Methods are poorly written. How do the authors isolate LPS from Pg? The authors should describe the strain of Pg you selected.</p>
                <p> </p>
                <p> 
                    <bold>Answer: </bold>The 
                    <italic>Porphyromonas gingivalis</italic> strains W50 and W83 were obtained from the culture collection of Institute of Tropical Disease Universitas Airlangga. The purified LPS was solubilized in sample buffer to the desired concentration (1 mg/mL), and boiled for 5 min with denatured proteins in a hot MgCl
                    <sub>2</sub>-Triton X-100 solution, solubilization with EDTA-Triton X-100 and precipitation with MgCl
                    <sub>2</sub>.&#x00a0;After that, 16 &#x00b5;L/well from each sample was separated on 15% SDS gel with a 4% stacking gel under reducing condition at 100 mA for 2 hr using mini-PROTEAN electrophoresis instrument (Bio-Rad Laboratories, California, USA). Silver and coomassie blue staining of the gels was performed according to the standard protocol. Staining of agarose gel with ethidium bromide was done as well in order to show if any contamination with nucleic acids persist. To do this, 10 &#x00b5;L/well of reconstituted LPS from 
                    <italic>Porphyromonas gingivalis</italic> and also 10 &#x00b5;L/well bacterial suspensions (10
                    <sup>8</sup> CFU/ mL), as positive control, were loaded on agarose gel and stained with ethidium bromide.</p>
                <p> Discussion, page 8, third line from the back: wrong reference papers are cited.</p>
                <p> </p>
                <p> 
                    <bold>Answer:</bold> thank you for your suggestion, after discussion among co-authors, we have replaced that reference you mentioning.</p>
                <p> </p>
                <p> LPS Pg should be Pg LPS.</p>
                <p> </p>
                <p> 
                    <bold>Answer: </bold>thank you for your feedback. We have replaced LPS Pg with Pg LPS</p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report92329">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.55174.r92329</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Alvarez</surname>
                        <given-names>Carla</given-names>
                    </name>
                    <xref ref-type="aff" rid="r92329a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r92329a1">
                    <label>1</label>The Forsyth Institute, Cambridge, MA, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>31</day>
                <month>8</month>
                <year>2021</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2021 Alvarez C</copyright-statement>
                <copyright-year>2021</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport92329" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.51959.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The Manuscript by Nelwan
                <italic> et al.</italic> presents a pilot study where they administer different concentrations of Pg LPS by Intra-sulcular injection to rats and then analyzed the IgE and IgG4 after 0, 4, and 11 days in the peripheral blood serum by ELISA. The results are that Pg injection increased both IgE and IgG4 at days 4 and 11 post-injection. IgE concentration was increased to a higher extend than IgG4.</p>
            <p> </p>
            <p> 
                <bold>Overall Comments:</bold> 
                <list list-type="bullet">
                    <list-item>
                        <p>Even though the study is simple in its design and results, the data analysis results layout (plots and tables) and all sections are very confusing. The study is presented as a pilot study (small experimental study), yet they provided a sufficient sample size to achieve statistical significance, which needs to include an appropriately detailed analysis.</p>
                    </list-item>
                </list> </p>
            <p> 
                <bold>Specific comments:</bold> 
                <list list-type="bullet">
                    <list-item>
                        <p>The introduction does not explain why the authors decided to perform this study. The sentence: &#x2018;Since humoral immune responses are stimulated following Pg infection, there might be a link to the occurrence of atopy&#x2019; is extremely vague. There are no references to support that connection of ideas.</p>
                    </list-item>
                    <list-item>
                        <p>The link between periodontitis and atopy is not explained, and the literature does not back several statements. For instance, the sentence &#x201c;Rather than alveolar bone and ligament destruction, Pg&#x00a0;
                            <underline>is believed</underline>&#x00a0;to be involved with the development of atopic responses in a susceptible host&#x201d; has as reference Sperr
                            <italic> et al.</italic>: Prevalence of Comorbidities in Periodontitis Patients Compared to the General Austrian Population. J Periodontol. 2018; 89(1): 19&#x2013;27. What authors believe that Pg is involved in the development of atopic responses in a host? And why? These are critical elements missing in the introduction.</p>
                    </list-item>
                    <list-item>
                        <p>The sentence &#x201c;there is an&#x00a0;
                            <underline>unequivocally accepted fact&#x00a0;</underline>that the&#x00a0;
                            <underline>prevalence of atopy increases</underline>&#x00a0;more&#x00a0;
                            <underline>among children who have periodontal pathogen colonization</underline>&#x00a0;or infection&#x201d; is a bold statement with no literature backup. The paper cited is Dowarah R 
                            <italic>et al.</italic>: Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health, and antioxidant status in weaned piglets. PLoS One. 2018; 13(3): e0192978. How does that paper in piglets explain that unequivocally accepted fact in human children?</p>
                    </list-item>
                    <list-item>
                        <p>A proper introduction must explain all the variables studied in the paper and present them in an organized and coherent way. The knowledge gap must be evident and support the hypothesis established by the authors and the experimental design. All this, using solid references that can accurately backup the statements as are presented.</p>
                    </list-item>
                    <list-item>
                        <p>The results should be three grouped graphs: IgE and IgG4 concentrations, then the ratio of them, that&#x2019;s it. There is no need for most tables, and the graphs should show which group is significantly different from another group by using asterisks. The authors should use a posthoc analysis after ANOVA to show the individual comparisons in the graph.</p>
                    </list-item>
                    <list-item>
                        <p>The discussion is very confusing; the authors often change the topic or don&#x2019;t explain the point they try to make. Also, several statements have no literature references, such as &#x201c;Th-1 and Th-2 cells are not two different CD4+ T-cell subsets, but it represents polarized forms of the highly heterogenous CD4+ Th cell-mediated immune response&#x201d;, is again a bold statement with no references. Please check the relevant literature.</p>
                    </list-item>
                    <list-item>
                        <p>I suggest including in your discussion the following elements:</p>
                        <p> What are the significant findings of the study, their meaning, and why are they important? Relate the results to those of similar studies. Clarify alternative explanations of your results. State what is the relevance of the conclusions in the clinical scenario. Suggest future studies and provide a conclusion with a take-home message.</p>
                        <p> Don&#x2019;t overinterpret the results, provide unwarranted speculation or explain tangential issues.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>No</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>No</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Periodontology, Immunology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment11352-92329">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Nugraha</surname>
                            <given-names>Ricardo Adrian</given-names>
                        </name>
                        <aff>Cardiology and Vascular Medici, Airlangga University, Surabaya, East Java, Indonesia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>None declared</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>1</day>
                    <month>4</month>
                    <year>2024</year>
                </pub-date>
            </front-stub>
            <body>
                <p>
                    <list list-type="bullet">
                        <list-item>
                            <p>Even though the study is simple in its design and results, the data analysis results layout (plots and tables) and all sections are very confusing. The study is presented as a pilot study (small experimental study), yet they provided a sufficient sample size to achieve statistical significance, which needs to include an appropriately detailed analysis.</p>
                        </list-item>
                    </list> 
                    <bold>Answer:</bold> thank you for your comment. We have included statement &#x201c;this study had limitations with regard to very small number of samples which can increase the likelihood of error and imprecision&#x201d; in the Limitation subsection, thus readers should be careful when interpreted results of our study.</p>
                <p> &#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>The introduction does not explain why the authors decided to perform this study. The sentence: &#x2018;Since humoral immune responses are stimulated following Pg infection, there might be a link to the occurrence of atopy&#x2019; is extremely vague. There are no references to support that connection of ideas.</p>
                        </list-item>
                    </list> 
                    <bold>Answer: </bold>Thank you for your suggestion. We chose to delete statement &#x2018;Since humoral immune responses are stimulated following Pg infection, there might be a link to the occurrence of atopy&#x2019;</p>
                <p> &#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>The link between periodontitis and atopy is not explained, and the literature does not back several statements. For instance, the sentence &#x201c;Rather than alveolar bone and ligament destruction, Pg&#x00a0;
                                <underline>is believed</underline>&#x00a0;to be involved with the development of atopic responses in a susceptible host&#x201d; has as reference Sperr
                                <italic>&#x00a0;et al.</italic>: Prevalence of Comorbidities in Periodontitis Patients Compared to the General Austrian Population. J Periodontol. 2018; 89(1): 19&#x2013;27. What authors believe that Pg is involved in the development of atopic responses in a host? And why? These are critical elements missing in the introduction.</p>
                        </list-item>
                    </list> 
                    <bold>Answer: </bold>Thank you for your very constructive feedback. We have replaced the references to support our statement. Takaoka et al (2022) reported an estimate of the RR and OR between metal allergy, periodontitis, and PPP in patients who visited a dental metal allergy clinic. It was shown that the periodontal disease risk was 2.54 times higher in patients with PPP than in PPP-negative patients. The OR for periodontal disease between patients with PPP and the PPP-negative patients in the national average was 2.63. 
                    <list list-type="bullet">
                        <list-item>
                            <p>The sentence &#x201c;there is an&#x00a0;
                                <underline>unequivocally accepted fact&#x00a0;</underline>that the&#x00a0;
                                <underline>prevalence of atopy increases</underline>&#x00a0;more&#x00a0;
                                <underline>among children who have periodontal pathogen colonization</underline>&#x00a0;or infection&#x201d; is a bold statement with no literature backup. The paper cited is Dowarah R&#x00a0;
                                <italic>et al.</italic>: Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health, and antioxidant status in weaned piglets. PLoS One. 2018; 13(3): e0192978. How does that paper in piglets explain that unequivocally accepted fact in human children?</p>
                        </list-item>
                    </list> 
                    <bold>Answer:</bold> thank you for your correction. We have replaced that references with Teles F et al (2022) who investigates the biological basis of the connections between periodontal diseases and systemic allergic conditions which generally emphasized the bacteriome. 
                    <list list-type="bullet">
                        <list-item>
                            <p>A proper introduction must explain all the variables studied in the paper and present them in an organized and coherent way. The knowledge gap must be evident and support the hypothesis established by the authors and the experimental design. All this, using solid references that can accurately backup the statements as are presented.</p>
                        </list-item>
                    </list> 
                    <bold>Answer: </bold>thank you for your very well suggestion. We try to make more proper introduction according to your suggestion. 
                    <list list-type="bullet">
                        <list-item>
                            <p>The results should be three grouped graphs: IgE and IgG4 concentrations, then the ratio of them, that&#x2019;s it. There is no need for most tables, and the graphs should show which group is significantly different from another group by using asterisks. The authors should use a posthoc analysis after ANOVA to show the individual comparisons in the graph.</p>
                        </list-item>
                    </list> 
                    <bold>Answer:</bold> thank you for your suggestion, but we decided to show the tables for the readers to easier understanding the analysis behind each graphs.</p>
                <p> &#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>The discussion is very confusing; the authors often change the topic or don&#x2019;t explain the point they try to make. Also, several statements have no literature references, such as &#x201c;Th-1 and Th-2 cells are not two different CD4+ T-cell subsets, but it represents polarized forms of the highly heterogenous CD4+ Th cell-mediated immune response&#x201d;, is again a bold statement with no references. Please check the relevant literature.</p>
                        </list-item>
                    </list> Even though thank you for your very well suggestion. We try to make more proper discussion according to your suggestion and add the references for our statement.</p>
                <p> &#x00a0; 
                    <list list-type="bullet">
                        <list-item>
                            <p>I suggest including in your discussion the following elements:</p>
                            <p> What are the significant findings of the study, their meaning, and why are they important? Relate the results to those of similar studies. Clarify alternative explanations of your results. State what is the relevance of the conclusions in the clinical scenario. Suggest future studies and provide a conclusion with a take-home message.</p>
                            <p> Don&#x2019;t overinterpret the results, provide unwarranted speculation or explain tangential issues.</p>
                        </list-item>
                    </list> 
                    <bold>Answer:</bold> thank you for your very well suggestion. We try to make more proper discussion according to your suggestion.</p>
            </body>
        </sub-article>
    </sub-article>
</article>
